2026年1月启动的新国家方案将脑肿瘤患者与临床试验连接起来, 目的是改善Natalie2021年死亡后获得治疗的机会。 A new national program launched in Jan 2026 connects brain tumor patients with clinical trials, aiming to improve access following Natalie’s 2021 death.

2026年1月启动了一项新的国家举措,即 " 脑肿瘤临床试验(ACT-BT) " ,目的是在2021年来自Warwickshire的31岁的Natalie死亡后,改善患者获得临床试验的机会。 Natalie在2017年与2017年诊断的脑肿瘤进行了战斗。 A new national initiative, Access to Clinical Trials for Brain Tumours (ACT-BT), launched in January 2026, aims to improve patient access to clinical trials after the 2021 death of 31-year-old Natalie from Warwickshire, who battled a brain tumour diagnosed in 2017. 她的母亲Liz Paul帮助开发了由脑肿瘤慈善协会和利兹大学共同创建的系统,通过一个全国专家小组将病人与适当的试验联系起来。 Her mother, Liz Paul, helped develop the system, co-created by The Brain Tumour Charity and the University of Leeds, to connect patients with suitable trials through a national panel of experts. 这项工作解决了认识低和地理差异等障碍,目的是扩大对延长生命研究的参与。 The effort addresses barriers like low awareness and geographic disparities, with the goal of expanding participation in life-extending research.